Peter L. Roberson

University of Michigan–Ann Arbor — United States

Physics and Astronomy · Physical Sciences

28h-index2.5kcitations98works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Radiotherapy Techniques(47), Radiopharmaceutical Chemistry and Applications(28), Medical Imaging Techniques and Applications(21), Prostate Cancer Diagnosis and Treatment(15), Radiation Therapy and Dosimetry(14)

Publications98 total

Prediction of Tumor Control in <sup>90</sup>Y Radioembolization by Logit Models with PET/CT-Based Dose Metrics
Journal of Nuclear Medicine·2019· 50 citedOpen Access
Logistic regression models for accurate prediction of tumor control using radiobiologic dose metrics in Y-90 radioembolization
2019
Impact of 90Y PET gradient-based tumor segmentation on voxel-level dosimetry in liver radioembolization
EJNMMI Physics·2018· 10 citedOpen Access
Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin Lymphoma
Cancer Biotherapy and Radiopharmaceuticals·2017· 2 citedOpen Access
The role of spirituality in the wellbeing of community health care workers at Temba Community Development Services
Unisa Institutional Repository (University of South Africa)·2016Open Access
Development of a brachytherapy audit checklist tool
Brachytherapy·2015· 3 cited
Development of a Comprehensive, Brachytherapy Audit Checklist
Brachytherapy·2015Open Access
Using a 2D detector array for meaningful and efficient linear accelerator beam property validations
Journal of Applied Clinical Medical Physics·2014· 6 citedOpen Access
Tumor-Absorbed Dose Predicts Progression-Free Survival Following <sup>131</sup>I-Tositumomab Radioimmunotherapy
Journal of Nuclear Medicine·2014· 57 citedOpen Access
Biological-Effect Modeling of Radioimmunotherapy for Non-Hodgkins Lymphoma: Determination of Model Parameters
Cancer Biotherapy and Radiopharmaceuticals·2013· 2 citedOpen Access
Investigation of effect of variations in bone fraction and red marrow cellularity on bone marrow dosimetry in radio-immunotherapy
Physics in Medicine and Biology·2013· 14 citedOpen Access
SU‐E‐J‐186: Automated SPECT‐Based Segmentation for Quality Assurance of CT‐Delineated Tumor Volumes for 131I Tositumomab Therapy of Non‐Hodgkins Lymphoma
Medical Physics·2013· 6 cited
MIRD Pamphlet No. 23: Quantitative SPECT for Patient-Specific 3-Dimensional Dosimetry in Internal Radionuclide Therapy
Journal of Nuclear Medicine·2012· 384 citedOpen Access
Audit tool for external beam radiation therapy departments
Practical Radiation Oncology·2012· 5 cited
Quantitative Bremsstrahlung SPECT/CT image reconstruction with patient specific Monte Carlo scatter compensation for Y-90 microsphere radioembolization (RE)
2012· 1 cited
Investigation of effect of variations in bone fraction and red marrow cellularity on bone marrow dosimetry in I-131 radioimmunotherapy (RIT)
2012
Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin’s lymphoma
European Journal of Nuclear Medicine and Molecular Imaging·2010· 9 cited
Analysis of variation in calibration curves for Kodak XV radiographic film using model‐based parameters
Journal of Applied Clinical Medical Physics·2010· 6 citedOpen Access
<sup>131</sup>I-Tositumomab Radioimmunotherapy: Initial Tumor Dose–Response Results Using 3-Dimensional Dosimetry Including Radiobiologic Modeling
Journal of Nuclear Medicine·2010· 92 citedOpen Access
SU‐GG‐T‐317: Investigation of Dosimetric Characteristics for Lung Tumor Geometries for a 6 MV Photon Beam
Medical Physics·2010
page 1 of 5Next →

Frequent Co-authors

Patrick W. McLaughlin(10), Yuni K. Dewaraja(9), Vrinda Narayana(7), Donald J. Buchsbaum(7), S.J. Wilderman(6), Jean M. Moran(6), R. J. Powers(6), R.J. Winfield(5), Benedick A. Fraass(5), Sara Troyer(5), Matthew J. Schipper(5), Randall K. Ten Haken(5), A. Zehnder(5), A. R. Kunselman(5), Lon Marsh(4), Mark Kaminski(4), Anca M. Avram(4), R. E. Welsh(4), F. Boehm(4), Marc L. Kessler(3)